A phase 1b–2 trial published in The New England Journal of Medicine evaluated the combination of two bispecific antibodies, talquetamab and teclistamab, for patients with relapsed or refractory multiple...
Recent studies examine metformin for long COVID prevention, resistance exercise for post-COVID recovery, mRNA vaccines in cancer care, and vascular risks in children.
Treatment with lumasiran improved kidney outcomes in patients with primary hyperoxaluria type 1, with no cases of end-stage kidney disease observed during follow-up in a study presented at Kidney Week....
In a recent presentation at Practical Updates in Primary Care, Joel M. Gelfand, MD, provided an overview of psoriasis care for primary care providers alongside co-presenter Annie Truss, MD. In this...
The Consultant360 Multidisciplinary Roundtable on the September 2025 ACIP (Advisory Committee on Immunization Practices) updates brought together leading vaccine experts—including Drs Bonnie Maldonado, Art...
Veteran dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares practical insights on how he incorporates ZORYVE® (roflumilast) into the treatment of atopic dermatitis, seborrheic...
The November issue of Consultant brings together a diverse collection of case reports, from rare vascular emergencies to transplant-related complications and persistent hip pain following a fall. With each...
In this episode of Ask the Experts, dermatology Physician Assistant Douglas DiRuggiero, PA-C, DMSc, shares what's unique about the formulations of ZORYVE® (roflumilast). Mr. DiRuggiero discusses how...
A 35-year-old woman with systemic lupus erythematosus, antiphospholipid syndrome, chronic urticaria, asthma, Hashimoto thyroiditis, and recurring seizures presented to dermatology with a 3-month rash.
...
A 29-year-old woman with systemic lupus erythematosus (SLE) and a history of hypertension presented to the emergency department with acute chest pain and lower extremity paresthesia.
A 56-year-old Black man presented at the dermatology clinic with patchy scalp hair loss that began 4 months after receiving his second COVID-19 vaccination. The patient’s past medical history was remarkable...
Advanced or recurrent endometrial cancer has long meant limited paths forward. But that may be changing. In this short video, two experts share compelling phase 3 data on a treatment option and what it could mean for real-world care.
